Loading provider…
Loading provider…
Neurology Physician in Boston, MA
NPI: 1083789556Primary Practice Location
BOSTON MEDICAL CENTER
1 Boston Medical Ctr Pl, Boston, MA
Primary Employer
Boston University Neurology Associates, Inc.
bmc.org
HQ Phone
Get MD, PHD Konstantin's Phone Numberphone_androidMobile
Get MD, PHD Konstantin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MA State Medical License
2004 - 2027
NJ State Medical License
2005 - 2025
NY State Medical License
2009 - 2011

American Board of Psychiatry and Neurology
Neurology
Harvard Medical School
hms.harvard.edu
Fellowship • 1992 - 1995
1992 - 1995
JFK Medical Center
Residency • Neurology
2001 - 2004
Brooklyn Hospital Center
Residency • Internal Medicine
1999 - 2000
Russian Academy of Medical Sciences
PhD • 1983 - 1986
1983 - 1986
Russian State Medical University
MD • Medicine
1977 - 1983
Medical School
Until 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99223Initial hospital inpatient care, typically 70 minutes per day | 26 | 26 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 24 | 32 |
| 3 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | 29 |
[Characteristics of the set-up of the lymphocyte blast transformation reaction using whole blood].
Authors: Balashov, K E, Boĭko, A N, Glazko, A V, Sidorenko, I V, Shul'zhenko, A E, Borisova, A M, Karaulov, A V
Journal: Lab Delo
Fibrinolysis induced clinical improvement in a patient with multiple sclerosis exacerbation.
[Natural antitumor cytotoxicity of the whole blood of donors and cancer patients].
Authors: Balashov, K. E., Letiagin, V. P., Ozherel'ev, A. S., Ole?nikova, O. M., Kadagidze, Z. G.
Lead Sponsor: Rutgers, The State University of New Jersey
Collaborators: Bayer
Intervention / Treatment: DRUG: Interferon-beta 1b (Betaseron)